anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

229,681-229,740 of 319,975

filter-aware
11
Uses a 'hypocrisy' framing by juxtaposing corporate values against specific actions.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
12
The slide uses visual evidence (screenshots of the opponent's deck) to expose a lack of transparency.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
13
The slide includes a screenshot of a page from a Disney investor presentation (page 45) to support the argument.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
14
Blackwells Capital | Activist Presentation Deck | 15 slidesBlackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · TimelineLoop · Cost Of Inaction1 hit
15
Blackwells Capital | Activist Presentation Deck | 15 slidesBlackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Demand ListLoop · Cost Of Inaction1 hit
01
Slide 1
Includes company logo, tagline, and date.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
02
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
03
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
04
Includes a 'Fierce Biotech Fierce 15' award badge.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
05
The slide uses a visual comparison framework to contrast current standard-of-care targets (mutations/fusions) with the company's focus (ecDNA).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Problem (Identify pain)1 hit
06
The slide uses a horizontal bar chart format to represent a drug development pipeline.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Problem (Identify pain)1 hit
07
The slide uses a grid layout to present six key executives, each with their name, title, and a list of logos representing their past professional experience.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Problem (Identify pain)1 hit
08
The slide uses a grid layout for headshots and a vertical column for investor logos.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Problem (Identify pain)1 hit
09
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Problem (Identify pain)1 hit
10
The slide uses Kaplan-Meier survival curves to illustrate the clinical problem.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
11
The slide uses a visual 'X' to indicate the lack of efficacy for amplifications across multiple drug classes.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
The slide uses a color-coded matrix to illustrate clinical failure or limited efficacy in amplified tumors.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
13
The slide uses a horizontal timeline to map scientific discovery (Nature/Science papers) against corporate milestones (funding, clinical trials).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
14
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
15
The slide uses a combination of microscopy images, a circular genomic plot (circos plot), and a diagram of cell division to illustrate the mechanism.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
16
Data source: Kim, Nguyen, Turner, et al. 2020 Nature Genetics. Analysis of WGS data from >3,000 tumor and matched normal samples.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
17
The slide uses a stacked bar chart to show amplification types and a Kaplan-Meier survival curve to show patient outcomes.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
18
The slide uses a before-and-after experimental setup with microscopy images and longitudinal data plots to illustrate therapeutic resistance.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
19
The slide uses two distinct experimental examples (sequential vs combination inhibition) to illustrate the mechanism of resistance via ecDNA.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
20
Uses a 'Whac-a-Mole' analogy to illustrate the limitations of current targeted therapies versus the company's proposed solution.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
21
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
22
The slide uses a telescope metaphor to represent the 'Spyglass' platform, focusing on ecDNA biology.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
23
The slide uses a circular process diagram to map drug candidates to biological mechanisms.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
24
The slide uses a hub-and-spoke diagram to show how the ECHO algorithm integrates into existing clinical NGS workflows to identify patients with ecDNA-driven cancers.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
25
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
26
The slide uses a comparative visual framework to contrast normal vs. stressed replication mechanisms.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
27
The slide uses a combination of a CRISPR screen scatter plot and a biological process diagram to illustrate the mechanism.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
28
Uses a puzzle piece metaphor to represent the components of a successful therapeutic strategy.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
29
Includes kinase selectivity tree and four tumor volume growth inhibition charts.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
30
Includes a mechanism of action diagram illustrating 'Therapy Enhanced Synthetic Lethality'.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
31
Shows synergistic effect of BBI-355 with Palbociclib and Erlotinib.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
32
The slide uses a process flow diagram to illustrate the progression from single-agent to combination therapy trials.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
33
The slide highlights the 60mg dose as the MTD (Maximum Tolerated Dose) and shows it crosses the threshold for tumor regression.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
34
The table uses a grid layout to show AE frequency across different dosage cohorts (20mg, 40mg, 60mg, 80mg Q2D, 80mg 2ON/5OFF, 120mg 2ON/5OFF).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
35
Includes legend for dose cohorts and patient IDs; visual evidence of biomarker induction via IHC staining.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
36
The slide uses a Gantt-style timeline to map trial phases against calendar years.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
37
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
38
The slide uses a table structure to map initial drivers to resistance mechanisms, supported by clinical citations and microscopy images.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
39
The slide uses a biological mechanism diagram to explain the therapeutic rationale for BBI-825.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
40
The slide uses a process flow (left to right) to demonstrate the mechanism of action and efficacy.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
41
Includes two distinct experimental setups: prevention of resistance (left) and treatment of established resistance (right).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
42
Includes FISH images, bar chart of copy number, Western blot, and a cell growth curve.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
43
The slide uses a 'STARMAP' acronym to describe the study design.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
44
The slide uses a diagram to link specific cancer types and mutations to resistance mechanisms, ultimately pointing to BBI-825 as the solution.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Market Size1 hit
45
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Market SizeLoop · Golden Circle1 hit
46
The slide uses two pie charts to represent patient populations and a central circular diagram to illustrate the biological nodes (Replication Stress, Assembly & Repair, Segregation).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Market SizeLoop · Golden Circle1 hit
47
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Loop · Golden Circle1 hit
48
The slide uses a timeline-style progression to frame the company's technology as the next logical evolution in cancer treatment.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Why NowLoop · Why Now1 hit
49
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Why NowLoop · Why Now1 hit
50
The chart at the bottom illustrates the 'ecDNA revolution' alongside 'Molecular biology' and 'NGS' revolutions.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
51
The table uses a clear contrast-based layout to differentiate the two lead molecules.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
01
Slide 1
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank 1 hit
02
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank 1 hit
03
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank 1 hit
04
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit